孔德涛（Tommy Kong）

药学硕士，毕业于北京大学，曾任职于上海恒瑞医药有限公司，负责美国FDA药品ANDA注册项目微生物与化学分析测试与卷宗制作等方面相关事务，现担任瑞欧科技（REACH24h,China）SIEF工作组组管，全面负责协调REACH法规联合注册各相关SIEF工作，与欧洲石油树脂与松香树脂（HAPPRA）建立了良好联系，是松香类物质REACH联合注册SIEF工作主要负责人，此外，所负责的氧化铝与环氧乙烷联合注册工作已经进入到了最后的个人卷宗递交阶段，预计2010-6即可获得正式注册号。此外，负责美国TSCA以及欧盟BPD法规应对研究。

Tommy Kong

Graduated from Peking University with Ms. (Pharmacy), Mr. Kong has been appointed as program manager for the US FDA generic drug application (ANDA) with respect to microbiology and chemistry in Shanghai Hengrui Pharma Co. Ltd, one leading Chinese local patent drug manufacture. Currently, as SIEF Coordinator, he fully is responsible to the SIEF Co-registration activities within REACH24h and has established well communication with HARRPA under REACH co-registration for gum rosin and other rosin derivatives, moreover, the co-registrations of Alumina and Ethylene Oxide have been approaching the completeness and successful joint submission could be available in Jun-2010. Besides the REACH Regulation, regulatory investigation and compliance studies on US TSCA and EU BPD are subject to Mr. Kong within REACH24h as well.